Business | NDTV Correspondent | Saturday November 26, 2011
Drug maker Lupin on Wednesday said it has received approval from the US health regulator to market Tramadol Hydrochloride Extended Release Tablets, used to treat chronic pain in adults, in the American market.
The company's subsidiary Lupin Pharmaceuticals Inc has received approval from US Food and Drug Administration (USFDA) for its abbrevi...
www.ndtv.com/business